Congress: Alzheimer's Association International Conference (AAIC) 2026
Dates: July 12-15, 2026
Location: ExCeL London, UK
Theme: Building the Roadmap to 2030
Overview
flowchart TD
events_aaic_2026_vascular_cogn["AAIC 2026 Vascular Contributions to Cognitive I"]
events_aaic_2026_vascular_cogn["Congress"]
events_aaic_2026_vascular_cogn -->|"related to"| events_aaic_2026_vascular_cogn
style events_aaic_2026_vascular_cogn fill:#81c784,stroke:#333,color:#000
events_aaic_2026_vascular_cogn["Alzheimer"]
events_aaic_2026_vascular_cogn -->|"related to"| events_aaic_2026_vascular_cogn
style events_aaic_2026_vascular_cogn fill:#81c784,stroke:#333,color:#000
events_aaic_2026_vascular_cogn["Association"]
events_aaic_2026_vascular_cogn -->|"related to"| events_aaic_2026_vascular_cogn
style events_aaic_2026_vascular_cogn fill:#81c784,stroke:#333,color:#000
events_aaic_2026_vascular_cogn["International"]
events_aaic_2026_vascular_cogn -->|"related to"| events_aaic_2026_vascular_cogn
style events_aaic_2026_vascular_cogn fill:#81c784,stroke:#333,color:#000
style events_aaic_2026_vascular_cogn fill:#4fc3f7,stroke:#333,color:#000
...Congress: Alzheimer's Association International Conference (AAIC) 2026
Dates: July 12-15, 2026
Location: ExCeL London, UK
Theme: Building the Roadmap to 2030
Overview
Mermaid diagram (expand to render)
Vascular contributions to cognitive impairment and dementia (VCID) represent a critical frontier in Alzheimer's disease research and represent a major focus at AAIC 2026. Growing evidence demonstrates that vascular pathology significantly modulates AD pathogenesis and that targeting the [neurovascular unit](/mechanisms/neurovascular-unit-signaling) offers promising therapeutic strategies["1"]. This page covers key sessions on [vascular dementia](/diseases/vascular-dementia), [cerebral small vessel disease](/mechanisms/cerebral-small-vessel-disease), [blood-brain barrier](/mechanisms/blood-brain-barrier-dysfunction) dysfunction, and the intersection of vascular and neurodegenerative processes.
Vascular Contributions to Alzheimer's Disease
Mixed Pathology: The Rule, Not the Exception
Autopsy studies reveal that the majority of dementia cases present with mixed pathology:
- Pure Alzheimer's: Only ~10-20% of dementia cases
- Mixed AD + vascular: ~40-50% of cases
- Vascular dementia alone: ~20-30% of cases[2]
This recognition has profound implications for diagnostic accuracy, treatment approaches, clinical trial design, and understanding disease progression.
Vascular Risk Factors
Key vascular risk factors discussed at AAIC 2026 include:
| Risk Factor | Mechanism | Impact on Cognition |
|-------------|-----------|---------------------|
| Hypertension | Small vessel damage | 2x dementia risk |
| Diabetes | Microvascular dysfunction | 1.5-2x dementia risk |
| Hyperlipidemia | Atherosclerosis | Accelerated decline |
| Smoking | Endothelial dysfunction | Direct neurotoxicity |
| Sedentary lifestyle | Reduced cerebral blood flow | Cognitive decline |
Related pages:
- [Vascular Risk Factors in Alzheimer's](/mechanisms/vascular-risk-factors-alzheimers)
- [Renin-Angiotensin System](/mechanisms/renin-angiotensin-system)
Cerebral Small Vessel Disease
Types of Small Vessel Pathology
Cerebral small vessel disease (CSVD) encompasses several pathological processes:
Lipohyalinosis: Fibrinoid necrosis of small vessels
Arteriolosclerosis: Wall thickening and luminal narrowing
Amyloid angiopathy: [Cerebral amyloid angiopathy](/mechanisms/cerebral-amyloid-angiopathy-pathway) (CAA)
Familial forms: [CADASIL](/diseases/cadasil), [CARASIL](/diseases/carasil)Imaging Markers
Key MRI biomarkers of CSVD include white matter hyperintensities, lacunes, microbleeds, enlarged perivascular spaces, and brain atrophy.
Related pages:
- [White Matter Hyperintensities](/mechanisms/white-matter-hyperintensities-pathogenesis)
- [Leukoaraiosis in Neurodegeneration](/mechanisms/leukoaraiosis-neurodegeneration)
Blood-Brain Barrier Dysfunction
The Neurovascular Unit
The [neurovascular unit](/mechanisms/neurovascular-unit-signaling) comprises endothelial cells (tight junctions), [pericytes](/mechanisms/pericyte-dysfunction), astrocyte end-feet, neuronal processes, and basement membrane.
BBB Breakdown in AD
Key mechanisms of [BBB dysfunction in cognitive impairment](/mechanisms/bbb-dysfunction-vascular-ci) include tight junction degradation, pericyte loss, transport disruption, and leukocyte infiltration.
Related pages:
- [Pericytes in Brain](/cell-types/pericytes)
- [Endothelial Cells](/cell-types/endothelial-cells)
Vascular Cognitive Impairment
Clinical Syndromes
[Vascular cognitive impairment](/diseases/vascular-cognitive-impairment) (VCI) encompasses vascular dementia (post-stroke, multi-infarct), subcortical vascular dementia (Binswanger disease), mixed dementia, and vascular mild cognitive impairment.
Related pages:
- [Mixed Dementia](/diseases/mixed-dementia)
- [Multi-Infarct Dementia](/diseases/multi-infarct-dementia)
Therapeutic Approaches
Current Strategies
Vascular-directed therapies discussed at AAIC 2026 include antihypertensives, statins, anti-platelet agents, and ACE inhibitors.
Related pages:
- [Vascular Dementia Treatment](/therapeutics/vascular-dementia-treatment)
- [BBB-Crossing Technologies](/technologies/bbb-crossing)
See Also
- [AAIC 2026 Conference](/events/aaic-2026)
- [AAIC 2026: Neuroinflammation](/events/aaic-2026-neuroinflammation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Vascular Dementia](/diseases/vascular-dementia)
- [Cerebral Small Vessel Disease Mechanism](/mechanisms/cerebral-small-vessel-disease)
- [Blood-Brain Barrier Mechanism](/mechanisms/blood-brain-barrier)
References
[Iadecola C, The pathobiology of vascular dementia (2013)](https://doi.org/10.1016/j.neuron.2013.10.008)
[Wardlaw JM et al., Neuroimaging standards for research into small vessel disease (2013)](https://doi.org/10.1016/S1474-4422(13)70124-5)
[Zlokovic BV, Neurovascular pathways to neurodegeneration in Alzheimer's disease (2011)](https://doi.org/10.1038/nrn3114)
[Sweeney MD et al., Blood-brain barrier: from physiology to disease and back (2019)](https://doi.org/10.1152/physrev.00014.2018)
[Schneider JA et al., Neuropathology of dementia subtypes in the oldest-old (2017)](https://doi.org/10.1212/WNL.0000000000004058)